Safety of Janssen Ad26.COV.S and Astra Zeneca AZD1222 COVID-19 Vaccines among Mobile Phone Users in Malawi: Findings from a National Mobile-Based Syndromic Surveillance Survey, July 2021 to December 2021
International Journal of Environmental Research and Public Health · 2023
DOI: 10.3390/ijerph20237123 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, 2023. Verfasst von Lucky Makonokaya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe P/Bag 2543, Malawi. Hauptthemen laut MEDLINE: COVID-19, Cell Phone. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PEPFAR, Centers for Disease Control and Prevention (CDC).
Abstract (Originalsprache)
The safety profiles of the Ad26.COV2.S and AZD1222 COVID-19 vaccines have not been described in the general population in Malawi. We present self-reported adverse events (AE) following the receipt of these vaccines in Malawi as part of a national syndromic surveillance survey. We conducted phone-based syndromic surveillance surveys among adults (≥18 years) with verbal consent. We used secure tablets through random digit dialing to select mobile phone numbers and collected data electronically. Survey questions included whether the respondent had received the COVID-19 vaccines, whether they had experienced any AE following vaccination, and the severity of the AE. We used multivariable analysis to identify factors associated with self-reported AE post-COVID-19 vaccination. A total of 11,924 (36.0%) out of 33,150 respondents reported receiving at least one dose of either Ad26.COV2.S or AZD1222 between July–December 2021; of those, 65.1% were female. About 49.2% of the vaccine recipients reported at least one AE, 90.6% of which were mild, and 2.6% were severe. Higher education level and concern about the safety of COVID-19 vaccines were associated with AE self-report (Adjusted Odds Ratio [AOR] 2.63 [95% CI 1.96–3.53] and 1.44, [95% CI 1.30–1.61], respectively), while male gender and older age were associated with reduced likelihood of AE self-report (AORs 0.81, [95% CI 0.75–0.88], 0.62 [95% CI 0.50–0.77], respectively). Ad26.COV2.S and AZD1222 vaccines are well-tolerated, with primarily mild and few severe AE among adults living in Malawi. Self-reporting of AE following COVID-19 vaccination is associated with gender, age, education, and concern about the safety of the vaccines. Recognizing these associations is key when designing and implementing COVID-19 vaccination communication messages to increase vaccination coverage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe P/Bag 2543, Malawi.
- Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC 20005, USA.
- Public Health Institute, Ministry of Health Malawi, Lilongwe P.O. Box 30377, Malawi.
ORCID-Profile: Lucky Makonokaya, Lester Kapanda, Godfrey B Woelk, Thulani Maphosa
Förderung
- PEPFAR
- Centers for Disease Control and Prevention (CDC)
Zitieren
APA
Makonokaya, L., Kapanda, L., Woelk, G. B., Chauma-Mwale, A., Kalitera, L. U., Nkhoma, H., Zimba, S., Chamanga, R., Golowa, C., Machekano, R., & Maphosa, T. (2023). Safety of Janssen Ad26.COV.S and Astra Zeneca AZD1222 COVID-19 Vaccines among Mobile Phone Users in Malawi: Findings from a National Mobile-Based Syndromic Surveillance Survey, July 2021 to December 2021. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph20237123
Vancouver
Makonokaya L, Kapanda L, Woelk GB, Chauma-Mwale A, Kalitera LU, Nkhoma H, et al. Safety of Janssen Ad26.COV.S and Astra Zeneca AZD1222 COVID-19 Vaccines among Mobile Phone Users in Malawi: Findings from a National Mobile-Based Syndromic Surveillance Survey, July 2021 to December 2021. International Journal of Environmental Research and Public Health. 2023. doi:10.3390/ijerph20237123
BibTeX
@article{Makonokaya2023,
author = {Makonokaya, Lucky and Kapanda, Lester and Woelk, Godfrey B and Chauma-Mwale, Annie and Kalitera, Louiser Upile and Nkhoma, Harrid and Zimba, Suzgo and Chamanga, Rachel and Golowa, Cathy and Machekano, Rhoderick and Maphosa, Thulani},
title = {Safety of Janssen Ad26.COV.S and Astra Zeneca AZD1222 COVID-19 Vaccines among Mobile Phone Users in Malawi: Findings from a National Mobile-Based Syndromic Surveillance Survey, July 2021 to December 2021},
journal = {International Journal of Environmental Research and Public Health},
year = {2023},
doi = {10.3390/ijerph20237123}
}
EUVIMED